These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1126966)

  • 61. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Antibodies to measles virus among the urban and rural population of the Andizhan Region].
    Klots VI; Babaiants RA; Niiazmatov BI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):115-6. PubMed ID: 6449812
    [No Abstract]   [Full Text] [Related]  

  • 63. Measles vaccination in infants.
    Jones PH
    JAMA; 1982 Mar; 247(9):1273-4. PubMed ID: 7062536
    [No Abstract]   [Full Text] [Related]  

  • 64. The immune response to aerosolized measles vaccine.
    Amler RW; Orenstein WA; Bart KJ
    JAMA; 1984 May; 251(18):2408. PubMed ID: 6708291
    [No Abstract]   [Full Text] [Related]  

  • 65. [Reaction to vaccination and measles antibody levels in children inoculated with vaccine prepared from the L-16 strain from Japanese quail embryonic fibroblast cultures].
    Zespolowa P
    Przegl Epidemiol; 1975; 29(3):291-300. PubMed ID: 1178922
    [No Abstract]   [Full Text] [Related]  

  • 66. Serological survey for rubella and measles antibodies among first graders.
    Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
    JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
    [No Abstract]   [Full Text] [Related]  

  • 67. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
    Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
    Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants.
    Altintaş DU; Evliyaoğlu N; Kilinç B; Sen'an DI; Güneşer S
    Eur J Epidemiol; 1996 Dec; 12(6):647-8. PubMed ID: 8982627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Serological examination in measles].
    Janout V
    Cesk Epidemiol Mikrobiol Imunol; 1979 Apr; 28(3):144-50. PubMed ID: 158438
    [No Abstract]   [Full Text] [Related]  

  • 74. [Systemic B-cell response in the mouse after mucosal immunization with measles virus].
    Muller CP; Brons NH
    Immun Infekt; 1994 Jun; 22(3):125-6. PubMed ID: 7927470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diploid cell measles vaccine.
    Fernández de Castro J; Valdespino Gómez JL; Díaz Ortega JL; Zárate Aquino ML
    JAMA; 1986 Aug; 256(6):714. PubMed ID: 3606740
    [No Abstract]   [Full Text] [Related]  

  • 76. [Results of observing the immunity dynamics in those inoculated with live Leningrad-16 and Schwartz measles vaccines].
    Zetilova LP; Bolotovskiĭ VM; Trufanova II; Abzalov KA; Duramshina NS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):95-8. PubMed ID: 4281242
    [No Abstract]   [Full Text] [Related]  

  • 77. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 78. [Measles antibody followed after measles vaccination: comparison with gelatin beads agglutination (PA) antibody, hemagglutination inhibition (HI) antibody and IgG-avidity].
    Saika S; Suzuki K; Ichinohe S
    Kansenshogaku Zasshi; 2003 Oct; 77(10):809-14. PubMed ID: 14608913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 80. Vindication of policy of vitamin A with measles vaccination.
    Ross DA; Cutts FT
    Lancet; 1997 Jul; 350(9071):81-2. PubMed ID: 9228955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.